Inventor · disambiguated record
Eric Wang
Also filed as: WANG ERIC · WANG ERIC Y · WANG ERIC YANJUN
33 granted patents·18 pending applications·1,716 citations·filing 1997–2024
98Inventor score
Files withEMISPHERE TECH INC19GUILFORD PHARM INC7BIVISION PHARMACEUTICALS INC3SIEMENS MEDICAL SOLUTIONS USA INC3KOLB HARTMUTH C2
Top patents by PatentIndex Score
51 records- 0198US6242495B1Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2000·Granted Jun 5, 2001·81 cites·11 claims
- 0298US5776888ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Jul 7, 1998·124 cites·21 claims
- 0398US5773647ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Jun 30, 1998·243 cites·23 claims
- 0497US7744910B2Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2006·Granted Jun 29, 2010·63 cites·81 claims
- 0597US6525020B2Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2001·Granted Feb 25, 2003·39 cites·16 claims
- 0697US6358504B1Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Mar 19, 2002·67 cites·16 claims
- 0797US6060513ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted May 9, 2000·95 cites·21 claims
- 0896US5990166ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Nov 23, 1999·87 cites·23 claims
- 0996US5879681ACompounds and compositions for delivering active agentsEMISPHERE TECHNOLGIES INC·Filed 1997·Granted Mar 9, 1999·165 cites·18 claims
- 1096US5863944ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Jan 26, 1999·88 cites·31 claims
- 1195US6313088B18-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Nov 6, 2001·69 cites·22 claims
- 1295US6051561ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Apr 18, 2000·80 cites·25 claims
- 1395US5939381ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Aug 17, 1999·73 cites·27 claims
- 1495US5876710ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Mar 2, 1999·88 cites·20 claims
- 1594US6693208B2Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2000·Granted Feb 17, 2004·45 cites·29 claims
- 1694US5804688ACompounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1997·Granted Sep 8, 1998·77 cites·21 claims
- 1793US7186414B2Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2005·Granted Mar 6, 2007·23 cites·81 claims
- 1893US6265609B1Thio-substituted pentanedioic acid derivativesGUILFORD PHARM INC·Filed 1999·Granted Jul 24, 2001·66 cites·35 claims
- 1990US8318132B2Imaging agents for detecting neurological dysfunctionKOLB HARTMUTH C·Filed 2009·Granted Nov 27, 2012·20 cites·9 claims
- 2089US6452044B2Benzenedicarboxylic acid derivativesGUILFORD PHARM INC·Filed 2001·Granted Sep 17, 2002·28 cites·38 claims
- 2188US8491869B2Imaging agents for detecting neurological disordersGANGADHARMATH UMESH B·Filed 2010·Granted Jul 23, 2013·10 cites·20 claims
- 2288US8420052B2Imaging agents useful for identifying AD pathologyKOLB HARTMUTH C·Filed 2009·Granted Apr 16, 2013·8 cites·23 claims
- 2385US10011632B2PSMA imaging agentsWANG ERIC·Filed 2012·Granted Jul 3, 2018·5 cites·39 claims
- 2480US7125910B2Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2003·Granted Oct 24, 2006·5 cites·1 claims
- 2574US6458775B1NAALADase inhibitors useful as pharmaceutical compounds and compositionsGUILFORD PHARM INC·Filed 1999·Granted Oct 1, 2002·30 cites·55 claims
- 2673US12139554B2PSMA imaging agentsSIEMENS MEDICAL SOLUTIONS USA INC·Filed 2020·Granted Nov 12, 2024·0 cites·11 claims
- 2773US12122851B2PSMA imaging agentsSIEMENS MEDICAL SOLUTIONS USA INC·Filed 2020·Granted Oct 22, 2024·0 cites·11 claims
- 2871US12427211B2Peptide-urea derivative, pharmaceutical composition containing same and application thereofBIVISION PHARMACEUTICALS INC·Filed 2024·Granted Sep 30, 2025·0 cites·16 claims
- 2971US6991798B1Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 1999·Granted Jan 31, 2006·33 cites·85 claims
- 3068US9023318B2Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereofCHEN GANG·Filed 2013·Granted May 5, 2015·1 cites·6 claims
- 3166US10894807B2PSMA imaging agentsSIEMENS MEDICAL SOLUTIONS USA INC·Filed 2018·Granted Jan 19, 2021·0 cites·36 claims
- 3265US6635786B2Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their useGUILFORD PHARM INC·Filed 2001·Granted Oct 21, 2003·2 cites·26 claims
- 3364US6852750B2Benzenedicarboxylic acid derivativesGUILFORD PHARM INC·Filed 2002·Granted Feb 8, 2005·1 cites·14 claims
- 3463US2015030540A1Imaging agents for detecting neurological dysfunctionLILLY CO ELI·Filed 2014·Application pending·0 cites
- 3560US2025319194A1Peptide-urea derivative, pharmaceutical composition containing same and application thereofBIVISION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3659US2013302248A1Imaging Agents for Detecting Neurological DisordersLILLY CO ELI·Filed 2013·Application pending·0 cites
- 3754US2025108139A1Peptide urea derivative, pharmaceutical composition containing peptide urea derivative, and application of peptide urea derivativeBIVISION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3854US2005171065A1Benzenedicarboxylic acid derivativesGUILFORD PHARM INC·Filed 2005·Application pending·0 cites
- 3953US2009203764A1Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseasesWANG ERIC YANJUN·Filed 2009·Application pending·0 cites
- 4050US2007078157A1Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO)enzyme activity and VAP-1 mediated adhesion useful for treatment of diseasesJOLLA PHARMA·Filed 2006·Application pending·0 cites
- 4149US2004063785A1Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their useGUILFORD PHARM INC·Filed 2003·Application pending·0 cites
- 4248US2007293548A1Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseasesWANG ERIC Y·Filed 2007·Application pending·0 cites
- 4347US2003083374A1NAALADase inhibitors useful as pharmaceutical compounds and compositionsFiled 2002·Application pending·0 cites
- 4447US2011212053A1Phosphatidylinositol 3 kinase inhibitorsQIAN DAPENG·Filed 2009·Application pending·0 cites
- 4545US2002119910A1Compounds and compositions for delivering active agentsEMISPHERE TECH INC·Filed 2000·Application pending·0 cites
- 4644US2006025438A1Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO) enzyne activity and VAP-1 mediated adhesion useful for treatment of diseasesSALTER-CID LUISA M·Filed 2005·Application pending·0 cites
- 4744US2005042274A1Compounds and compositions for delivering active agentsFiled 2003·Application pending·0 cites
- 4843US2012172392A1Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (ssao) enzyme activity and vap-1 mediated adhesion useful for treatment of diseasesSALTER-CID LUISA M·Filed 2012·Application pending·0 cites
- 4942US2005070719A1Inhibitors of dipeptidyl peptidase ivFiled 2002·Application pending·0 cites
- 5041US2005096360A1Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment of diseasesFiled 2004·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eric Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →